Midland, Michigan, United States
Successful business leader with strengths in business development, and private investments including venture capital, private equity, real estate and real assets. Transaction experience includes investments in emerging technology companies, funds private equity fund and direct investment structuring, corporate divestitures, IPO's and spin outs. Extensive experience in global business development for technology based businesses including life sciences, information technology and materials science. Skills: Venture Capital and Private Equity investment sourcing, due diligence, portfolio monitoring and management. Investment structuring, financing and capital structure management, and company valuation and financial analysis. Public company board experience at Seastar Medical (ICU) Pfenex, Inc. (PFNX), and numerous private company board and board observer roles. Understands and is trained in fiduciary role.
Advisor to management and board
Board of Directors and advisor to Gantec
Global team responsible for strategic planning, capital allocation and reporting, long term financial plan working in direct support of corporate strategy, strategic options and business analysis. Direct support to executive team and board. Additional responsibility for corporate venture investments, joint ventures, and special corporate projects. Ken was a member of the Investment Committee for the Dow pension plans.
Manage Alternative Investments across Private Equity, Real Estate and Real Assets as well as CIO of the Dow Canada Pension Plan.
Managed Alternative Investments for Dow's pension plans and insurance entities, including both fund and direct investment portfolios across Private Equity, Real Estate and Real Asset & Infrastructure. Sourcing, due diligence, investment monitoring. Also had role of Director of Dow Canada Pension Plan
Board Director through IPO (NYSE: PFNX) in 2014